
Y Combinator’s aggressive pivot to AI, with nearly half of its Spring 2025 cohort focused on AI agents, has sparked debate over hype versus substance. Controversies like PearAI’s product cloning highlight vetting issues and ethical concerns. Critics warn this may dilute quality and foster replication in a crowded field.
No discussion yet. Be the first to share your thoughts!